Homocysteine Levels and Your Genetics

By the ExomeDNA Research Team | Last reviewed May 25, 2026

Homocysteine is an amino acid that the body produces during the metabolism of methionine — an essential amino acid obtained from protein-rich foods. Unlike methionine, homocysteine has no nutritional role; instead, it is a byproduct that must be efficiently cleared through one of two enzymatic pathways. Genetics plays a meaningful role in shaping where circulating homocysteine tends to settle, with GWAS studies spanning more than a decade identifying loci tied to the enzymes that clear it, the cofactors they depend on, and the metabolic bridges between amino acid and nitrogen metabolism.

{{MEDICAL_DISCLAIMER}}

What is homocysteine?

Homocysteine is a sulfur-containing amino acid that sits at the intersection of two major metabolic routes. The first — remethylation — converts homocysteine back to methionine using a methyl group donated by 5-methyltetrahydrofolate (5-MTHF, produced by MTHFR), with methylcobalamin (vitamin B12) as the essential cofactor for methionine synthase (MTR). The second — transsulfuration — irreversibly converts homocysteine to cystathionine via cystathionine beta-synthase (CBS), using pyridoxal-5'-phosphate (vitamin B6) as cofactor. Cystathionine is subsequently hydrolyzed to cysteine, a precursor for glutathione synthesis.

Circulating homocysteine is normally maintained at low concentrations by the combined activity of these two pathways. When either is impaired — by genetic variation affecting enzyme activity, by B vitamin insufficiency reducing cofactor availability, or by kidney dysfunction impairing reabsorption of B vitamins — homocysteine accumulates in blood. Population-level GWAS studies have identified multiple loci affecting this balance, including genes encoding the clearance enzymes themselves, their cofactor supply chains, and related metabolic systems.

The genetics behind homocysteine levels

Genome-wide association studies have identified a network of genetic loci tied to circulating homocysteine concentrations, spanning transsulfuration, remethylation, cobalamin processing, nitrogen metabolism, and oxidative stress.

NOX4 (NADPH oxidase 4) ranks as the top-priority locus in this dataset. NOX4 is a constitutively active membrane enzyme that generates reactive oxygen species — specifically superoxide and hydrogen peroxide — expressed abundantly in the kidney and vascular endothelium. Homocysteine induces oxidative stress through multiple mechanisms, and NOX4 sits at the intersection of homocysteine biology and vascular redox chemistry. Variants in NOX4 may modulate how efficiently the vascular and renal environment handles the oxidative burden associated with elevated homocysteine, or may affect NOX4-driven signaling that feeds back on amino acid handling in the kidney. The NOX4 locus may also reflect a broader connection between renal ROS production and tubular amino acid handling.

CPS1 (Carbamoyl phosphate synthetase 1) catalyzes the first and rate-limiting step of the urea cycle in liver mitochondria, combining glutamate, bicarbonate, and ATP to produce carbamoyl phosphate. The urea cycle and the methionine cycle are metabolically intertwined through nitrogen economy: both process amino acid nitrogen, share aspartate as a nitrogen donor, and compete for common mitochondrial intermediates. CPS1 variants affect how efficiently the liver handles nitrogen flux from amino acid catabolism — including the nitrogen flowing through the methionine/homocysteine pathway. CPS1 activity is also regulated by N-acetylglutamate (NAG), connecting it to acetyl-CoA metabolism and feeding state, and its expression is sensitive to one-carbon and folate status — further linking it to the homocysteine system.

CUBN (Cubilin) encodes a large multiligand endocytic receptor expressed in the kidney proximal tubule and the small intestine. CUBN mediates the tubular reabsorption of several key circulating nutrients — including albumin, HDL components, folate, and critically the intrinsic factor–vitamin B12 complex. Because vitamin B12 (cobalamin) is the essential cofactor for methionine synthase (MTR), which remethylates homocysteine to methionine, CUBN function acts as a gatekeeper for B12 availability in the circulation. Variants that reduce CUBN function impair renal B12 reabsorption, reducing cobalamin availability for MTR and thereby slowing homocysteine clearance through the remethylation pathway. CUBN variants are among the better-replicated loci in homocysteine GWAS, reflecting the tight connection between renal nutrient handling and circulating amino acid balance.

CBS (Cystathionine beta-synthase) encodes the enzyme that commits homocysteine to the transsulfuration pathway by converting it — together with serine — to cystathionine, using pyridoxal-5'-phosphate (vitamin B6) as cofactor. This step irreversibly removes homocysteine from the methionine cycle. CBS is allosterically activated by SAM (S-adenosylmethionine), the universal methyl donor, which means CBS activity rises when methionine is abundant — creating a negative feedback loop that limits homocysteine accumulation. Pathogenic CBS mutations cause classical homocystinuria, a rare inborn error of metabolism characterized by severe hyperhomocysteinemia, lens dislocation, skeletal abnormalities, and thromboembolic risk. Common variation in CBS also contributes to population-level homocysteine differences, with lower-activity variants associated with modestly higher levels.

MTR (Methionine synthase) catalyzes the remethylation of homocysteine to methionine, using a methyl group from 5-methyltetrahydrofolate (produced by MTHFR) and methylcobalamin (B12) as cofactor. MTR is one of the two main enzymatic routes through which homocysteine is cleared; together with CBS, MTR and MTHFR constitute the core of homocysteine regulation. The MTR A2756G variant (p.Asp919Gly) is among the most studied common homocysteine-associated variants in the literature.

Additional ranked loci include MTHFR (methylenetetrahydrofolate reductase — produces the 5-MTHF substrate for MTR; C677T and A1298C are widely studied determinants of homocysteine), MMACHC (processes cobalamin intracellularly before it reaches both MTR and MMUT; MMACHC deficiency causes combined methylmalonic acidemia and homocystinuria), MMUT (methylmalonyl-CoA mutase — uses adenosylcobalamin for propionate metabolism, affecting cobalamin compartmentalization), FGF21 (fibroblast growth factor 21 — a metabolic hormone with roles in amino acid sensing and one-carbon metabolism regulation), and CHMP1A (ESCRT machinery protein implicated in lysosomal sorting, near a replicated locus).

Population context: GWAS studies spanning 2009–2024 have converged on a robust genetic architecture for circulating homocysteine, implicating both direct clearance enzymes (CBS, MTR) and their cofactor supply chains (CUBN for B12, MTHFR for folate-derived 5-MTHF). The convergence of these signals on the remethylation and transsulfuration pathways reflects how tightly homocysteine is biochemically controlled — and how precisely genetics can map onto that control architecture. [1–8]

What the research says

Research base: Robust.

Multiple genome-wide association studies published between 2009 and 2024 (PMIDs: 20031578, 20154341, 23696881, 23824729, 33623009, 34707639, 37479695, 38626723) have established a well-replicated genetic architecture for circulating homocysteine levels. Across studies, loci in the CBS–MTR–MTHFR axis replicate consistently, as does the CUBN locus linking renal B12 reabsorption to homocysteine clearance. The CPS1 and NOX4 loci have emerged in more recent large-scale analyses, extending the known genetic architecture into nitrogen metabolism and vascular redox biology.

The genetic findings are consistent with biochemical understanding of the clearance pathways: enzyme activity variants reduce clearance capacity; cofactor-handling variants decrease the efficiency of enzymatic reactions; and dietary inputs — B12, folate, and B6 — modulate how much genetic variation translates into actual differences in circulating homocysteine levels.

Study timeline: The homocysteine GWAS evidence base spans more than fifteen years, from large-scale analyses in 2009–2010 through a 2024 study. Key loci — CBS, MTR, MTHFR, and CUBN — have replicated consistently across diverse cohorts, making homocysteine genetics among the better-characterized circulating amino acid traits in the GWAS literature. [1–8]

References

1. Researchers et al. (2009). PMID: 20031578.
2. Researchers et al. (2010). PMID: 20154341.
3. Researchers et al. (2013). PMID: 23696881.
4. Researchers et al. (2013). PMID: 23824729.
5. Researchers et al. (2021). PMID: 33623009.
6. Researchers et al. (2021). PMID: 34707639.
7. Researchers et al. (2023). PMID: 37479695.
8. Researchers et al. (2024). PMID: 38626723.

How homocysteine levels affect you

Homocysteine is a normal metabolic intermediate — it arises inevitably when the body metabolizes methionine from protein-rich foods. At the population level, individuals with chronically higher circulating homocysteine tend to have a metabolic and vascular profile that differs from those with lower levels. Epidemiological cohort studies have observed associations between elevated homocysteine and cardiovascular and cerebrovascular phenotypes across many thousands of participants.

These are population-level associations, not personal predictions. Many people with genetic variants associated with higher homocysteine maintain levels within the normal range, because B vitamin intake — particularly folate and B12 — has a powerful moderating effect on the pathways that clear it. Homocysteine is one of the more nutrition-responsive circulating biomarkers, and the relationship between genetics and actual levels depends heavily on dietary B vitamin status.

Working with your result

Homocysteine levels respond substantially to dietary B vitamin intake. The three key nutrients that modulate the clearance pathways are:

• Folate (vitamin B9): provides 5-methyltetrahydrofolate (5-MTHF) for the MTR remethylation reaction; found in leafy greens, legumes, and fortified foods
• Vitamin B12 (cobalamin): essential cofactor for MTR; renal reabsorption is partly governed by CUBN; found in animal products, dairy, and eggs
• Vitamin B6 (pyridoxal-5'-phosphate): cofactor for CBS in the transsulfuration pathway; found in poultry, fish, potatoes, and bananas

In large interventional studies, B vitamin supplementation — particularly folate and B12 — consistently lowers circulating homocysteine in populations with higher baseline levels. The degree of response depends on underlying vitamin status and genetic background. Whether lowering homocysteine through B vitamin supplementation translates to measurable health benefit has been more mixed in randomized controlled trial data.

Anyone interested in their homocysteine level should work with a physician who can order a specific plasma homocysteine test and interpret it alongside B vitamin status and overall metabolic health.

Data sources: GWAS Catalog, Open Targets, ClinVar, ClinGen (accessed 2026-05-25).

This page is published by the ExomeDNA Research Team. Last reviewed: 2026-05-25.

Related traits and genes

Homocysteine metabolism intersects with several other circulating biomarkers and genetic traits. Related ExomeDNA traits include vitamin B12 levels, folate levels, and methylmalonic acid (a functional marker of B12 status that reflects MMUT and MMACHC activity). The MTHFR gene appears across homocysteine, neural tube defect risk, and one-carbon metabolism studies. CUBN variants also appear in albuminuria and vitamin B12 deficiency loci. CPS1 connects to urea cycle amino acid profiles and nitrogen metabolism phenotypes, with additional associations in fasting amino acid GWAS studies.

Frequently asked questions

What is homocysteine and why is it measured? Homocysteine is a sulfur-containing amino acid produced when methionine — found in meat, eggs, and dairy — is metabolized. It has no nutritional function; it is a byproduct that must be cleared by either remethylation back to methionine (requiring folate and B12) or transsulfuration to cystathionine (requiring B6). Some homocysteine is always present in blood; how much depends on clearance enzyme activity and B vitamin status. It is measured as a circulating biomarker because large population studies have observed associations between higher levels and cardiovascular phenotypes.

What does CBS do and why does it matter for homocysteine? CBS (cystathionine beta-synthase) irreversibly removes homocysteine from the methionine cycle by converting it to cystathionine, using vitamin B6 as cofactor. When CBS works efficiently — especially when stimulated by SAM, the body's main methyl donor — more homocysteine is permanently diverted to the transsulfuration pathway. Pathogenic CBS mutations cause classical homocystinuria with severe homocysteine accumulation. Common CBS variants also contribute to population-level differences in circulating homocysteine.

Why does CUBN appear in homocysteine genetics? CUBN (cubilin) is a receptor in the kidney that reabsorbs vitamin B12 from filtered blood back into the circulation. Without CUBN-mediated reabsorption, B12 would be lost in urine. Since B12 is an essential cofactor for methionine synthase (MTR) — the enzyme that remethylates homocysteine back to methionine — reduced CUBN function means less circulating B12, less MTR activity, and higher homocysteine. CUBN variants represent one of the best-replicated loci in homocysteine GWAS.

Can diet lower homocysteine levels? Yes, substantially. Folate, vitamin B12, and vitamin B6 are the primary nutritional modulators of homocysteine — they are cofactors and substrates for the two main clearance pathways. In people with higher baseline homocysteine, folate and B12 supplementation consistently lowers levels in intervention studies. The response is larger in people who are vitamin-deficient at baseline. Food sources include leafy greens and legumes (folate), animal products (B12), and poultry, fish, and potatoes (B6).

Is MTHFR the most important homocysteine gene? MTHFR is well-known but the genetics of homocysteine is multi-pathway. The MTHFR C677T variant reduces enzyme activity — particularly in TT homozygotes — and raises homocysteine modestly, especially when folate intake is low. However, CBS, MTR, CUBN, CPS1, and NOX4 each contribute independently through different biological routes. The effect of any single variant depends on which pathway it affects and how well that pathway is supported by dietary B vitamins.

{{FDAWELLNESSFOOTER}}